Article
New Processes With Parallel Bioreactors
January 5, 2012
Claudia M. Huether and Dr. Falk Schneider, DASGIP AG, Jülich
The pharmaceutical industry and regulatory authorities are facing new challenges in the development of new drugs that have complex interdependencies. Even at the early stage of process development, a number of detailed parameters have to be captured and large amounts of data must be analysed systematically. The following provides some insights into the more notable advantages of using process-integrated data management in tandem with parallel bioreacreactor systems.
A decade ago, the typical bioreactor fermentation process generally involved less than 15 process parameters, most of which were manually defined. Ten years on, bioreactor systems can easily capture more than 40 parameters automatically. This translates into more work for both the pharmaceutical industry and regulatory authorities when it comes to analysing and interpreting data.
© as published in European Biotechnology News No. 7-8, 2011
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
